United States Tissue Engineered Skin Substitutes Market Outlook to 2033 - Acellular Skin Substitutes and Cellular Skin Substitutes
Summary
GlobalData’s “United States Tissue Engineered Skin Substitutes Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Tissue Engineered Skin Substitutes market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Acellular Skin Substitutes and Cellular Skin Substitutes
The United States Tissue Engineered Skin Substitutes Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2023 company share and distribution share data for Tissue Engineered Skin Substitutes Market.
- Global corporate-level profiles of key companies operating within the United States Tissue Engineered Skin Substitutes Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United States Tissue Engineered Skin Substitutes is segmented as follows -
- Acellular Skin Substitutes
- Cellular Skin Substitutes
The United States Tissue Engineered Skin Substitutes Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Tissue Engineered Skin Substitutes Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Tissue Engineered Skin Substitutes Market, United States
- 3.1 Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
- 3.2.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Tissue Engineered Skin Substitutes Market, United States, Average Price ($) , 2018-2033
- 3.4 Tissue Engineered Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2023
- 3.5 Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2023.
- 4 Overview of Key Companies in United States, Tissue Engineered Skin Substitutes Market
- 4.1 Allergan Ltd
- 4.1.1 Company Overview
- 4.2 Integra LifeSciences Corp
- 4.2.1 Company Overview
- 4.3 MiMedx Group Inc
- 4.3.1 Company Overview
- 4.4 Organogenesis Holdings Inc
- 4.4.1 Company Overview
- 4.5 Smith & Nephew Plc
- 4.5.1 Company Overview
- 5 Tissue Engineered Skin Substitutes Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Acquisition
- 6.1.1 Surgalign Holdings (RTI Surgical) Acquires Cook Biotech from Cook Group
- 6.2 Equity Offerings
- 6.2.1 Harvard Apparatus Regenerative Technology Raises Approximately USD5 Million in Private Placement of Shares
- 6.2.2 Harvard Apparatus Regenerative Technology Raises USD1.5 Million in Private Placement of Shares
- 6.2.3 Surrozen to Raise Approximately USD192.5 Million in Private Placement of Shares
- 6.2.4 Chrysalis Biotherapeutics Raises USD0.51 Million in Equity Financing
- 7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Aug 27, 2024: Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
- 7.2 Financial Announcements
- 7.2.1 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
- 7.2.2 Nov 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results
- 7.2.3 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
- 7.3 Government and Public Interest
- 7.3.1 Apr 25, 2024: CMS Statement on Proposed Local Coverage Determination (LCD) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
- 8. Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- List of Tables
- Table 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Table 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Table 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Table 7: Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
- Table 8: Tissue Engineered Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
- Table 9: Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2023
- Table 10: Tissue Engineered Skin Substitutes Market Pipeline Products
- Table 11: Surgalign Holdings (RTI Surgical) Acquires Cook Biotech from Cook Group
- Table 12: Harvard Apparatus Regenerative Technology Raises Approximately USD5 Million in Private Placement of Shares
- Table 13: Harvard Apparatus Regenerative Technology Raises USD1.5 Million in Private Placement of Shares
- Table 14: Surrozen to Raise Approximately USD192.5 Million in Private Placement of Shares
- Table 15: Chrysalis Biotherapeutics Raises USD0.51 Million in Equity Financing
- Table 16: Total Number of Primary Research Participants, Wound Care Management Market, by Country
- List of Figures
- Figure 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Figure 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Figure 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
- Figure 7: Tissue Engineered Skin Substitutes Market, United States, Company Share (%) 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook